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RR3.
Left Subclavian Artery Coverage During Endovascular
Thoracic Aortic Repair and Risk of Perioperative
Stroke or Death
Matthew A. Corriere, Jayer Chung, Karthikeshwar Kasira-
jan, Ravi Veeraswamy, Thomas F. Dodson, Atef A. Salam,
Elliot L. Chaikof. Surgery, Division of Vascular Surgery
and Endovascular Therapy, Emory University School of
Medicine, Atlanta, GA
Objectives: Anatomic factors may dictate left subclavian
artery (LSA) coverage during endovascular thoracic aortic
repair (TEVAR); associations between LSA coverage, stroke,
and death are inconsistent in published reports. We examined
the 2005-2008 ACS-NSQIP data file to determine perioper-
ative risk of stroke or death after LSA coverage.
Methods: TEVAR procedures, LSA coverage, and
subclavian revascularization were identified by CPT codes.
Patients with simultaneous coronary, ascending or abdom-
inal aortic, or non-vascular abdominal procedures were
excluded. Associations between LSA coverage and 30-day
stroke and mortality were examined with logistic regres-
sion. Effects of subclavian revascularization with LSA cov-
erage were assessed with Fisher’s exact test.
Results: From 862 identified TEVAR procedures, 53
patients were excluded and 809 formed the basis of this
analysis. 279 procedures (38%) included LSA coverage;
subclavian revascularization was performed in 53 (7%).
30-day stroke and mortality rates were 5.2% and 7.1%. In
multivariate models, LSA coverage was associated with
perioperative stroke (OR 2.4; 95% CI 1.2-4.5; p  0.009)
and death (OR 1.9; 95% CI 1.0-3.6; p  0.042). Subcla-
vian revascularization was not associated with decreased
stroke or mortality in patients undergoing LSA coverage.
Conclusions: LSA coverage is associated with in-
creased risk of perioperative stroke and death; no protective
subclavian revascularization effect was observed.
Multivariate predictors of stroke and mortality.
Univariate p  0.10 for all displayed covariates.
Outcome Covariate OR (95% CI) P
Stroke Emergent procedure 3.10 (1.46-6.58) 0.003
Left subclavian artery coverage 2.36 (1.24-4.49) 0.009
Mortality Age (years) 1.46 (1.02-2.10) 0.041
WBC (1000/mL3) 1.35 (1.04-1.74) 0.024
Emergent procedure 2.23 (1.08-4.58) 0.030
Units PRBC transfused 1.26 (1.15-1.38) 0.001
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RR4.
Sideways Movement of the Endograft Within the An-
eurysm Sac Is Associated With Late Adverse Events
Evert Waasdorp2, Madhu Gorrepati1, Frans Moll2, Chris-
topher Zarins1. 1Vascular Surgery, Stanford University
Medical Hospital, Stanford, CA; 2University Medical Cen-
ter Utrecht, Utrecht, Netherlands.
Objectives: Previous studies have shown the impor-
tance of proximal and distal endograft fixation. There is
little information on the middle, unsupported section of
the endograft. We have quantified sideways movement of
the endograft within the AAA sac and correlated it to late
adverse events.
Methods: Patients who underwent EVAR between
January 1997 and December 2007 were analyzed. Patients
with a digital available preoperative CT-angiography
(CTA), postoperative CTA and at least one follow-up CTA
thereafter were included. Changes in endograft position
within the AAA sac were measured. Patients with sideways
movement 5mm were placed in the movement group
(MG) and were compared with patients with no movement
(5mm, NM group). To analyze the association of side-
ways endograft movement and EVAR related complication
the following outcomemeasures were noted: AAA rupture,
AAA-related death, conversion, secondary procedures,
AAA growth (5mm), proximal migration (10mm), and
new onset type 1/3 endoleaks.
Results: 144 patients (mean age 76 year) were
included. Follow-up was 43  27 months. Fifty patients
(35%) had sideways endograft movement. AAA diameter
(MG 60  9 vs NM 57  9mm, p  0.05), and proximal
and iliac endograft fixation lengths were significantly differ-
ent between the groups (MG 18  8 vs NM 25  11mm,
p 0.05 and MG 35 15 vs NM 42 16mm, p 0.05).
There was no significant difference between the groups in
terms of AAA rupture and AAA-related death (one fatal
AAA rupture, NM group). Patients in the MG group had a
significantly higher conversion rate (14 vs 0%, p  0.001)
and had more secondary procedures (44 vs 6%, p 0.001).
Patients in the MG had significantly more AAA growth (42
vs 10%, p  0.001), more proximal migration (66 vs 5%,
p  0.001) and more often type 1/3 endoleaks (36 vs 3%,
p  0.001).
Conclusions: Sideways movement of the device within
the AAA sac is associated with late adverse events. Con-
